drugset / Trial / NCT06438809

Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis

NCT06438809

Phase 1/2 Unknown 24 enrolled Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

A Phase I/II study to evaluate the safety and preliminary efficacy of human umbilical cord-derived mesenchymal stem cell injection for the treatment of chronic radiation proctitis.

Timeline

Start
2024-05-24
Primary completion
2025-05
Completion
2025-05

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 1.2e+08 cells Other

Indications